Skip to main content
. Author manuscript; available in PMC: 2018 Feb 22.
Published in final edited form as: Int J Drug Policy. 2017 Aug 12;47:196–201. doi: 10.1016/j.drugpo.2017.07.021

Table 2.

Characteristics of patients treated for hepatitis C virus infection at an urban primary care clinic who experienced virologic relapse.

VRa case Drug use, drug treatment category Treatment regimen Genotype Treatment experience Baseline viral load Cirrhosis
1 No active drug use, no OAT pegIFNb/RBVc/SOFd
12 weeks
1 No 2638421 yes
2 Active drug use, receiving OAT SOF/LDVe
12 weeks
1 No 29384170 no
a

Virologic relapse.

b

Pegylated interferon.

c

Ribavirin.

d

Sovaldi.

e

Ledipasvir.